CACNA1B

protein-coding

calcium voltage-gated channel subunit alpha1 B, the group of Calcium voltage-gated channel alpha1 subunits|EF-hand domain containing

Gene summary

The protein encoded by this gene is the pore-forming subunit of an N-type voltage-dependent calcium channel, which controls neurotransmitter release from neurons. The encoded protein forms a complex with alpha-2, beta, and delta subunits to form the high-voltage activated channel. This channel is sensitive to omega-conotoxin-GVIA and omega-agatoxin-IIIA but insensitive to dihydropyridines. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]

Previous symbols:
  • CACNL1A5

MANE transcript

NM_000718.4

Inheritance

AR, AD

ClinVar variants

P:61U:678B:659

Top phenotype

Dystonia 23

gnomAD constraint

pLI —, LoF o/e 0.16

Max pathogenic AF

—

Genomic locus

chr9:137,877,782-138,124,624

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~246.8 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movementsLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0032784

Submitter: Ambry Genetics

neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movementsMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0032784

Submitter: Illumina

neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movementsSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0032784

Submitter: G2P

complex neurodevelopmental disorder with motor featuresMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0100516

Submitter: ClinGen

*CACNA1B* encodes the (α1B) pore-forming subunit of the N-type voltage-gated calcium channel. *CACNA1B* was first reported in relation to autosomal recessive complex neurodevelopmental disorder with motor features in 2019 (Gorman KM et al., PMID: 30982612). Four variants have been reported in 6 children from 3 unrelated families, in one publication; all probands presented with early onset epileptic encephalopathy, severe neurodevelopmental delay with regression, and hyperkinetic movement disorder (PMID: 30982612). A different publication reported on a proband with a compound deep intronic splicing variant and missense variant. However, due to the high variant frequencies in gnomAD, the pathogenicity of these variants is unclear and these were not scored (PMID: 37095367). To date, no experimental evidence supports the relationship between *CACNA1B* and AR complex neurodevelopmental disorder with motor features. In summary, there is MODERATE evidence to support this gene-disease relationship. The ClinGen Cerebral Palsy Working Group approved this classification on August 21, 2023 (SOP Version 9).

neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movementsSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0032784

Submitter: Labcorp Genetics (formerly Invitae)

undetermined early-onset epileptic encephalopathySUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0018614

Submitter: Orphanet

Clinical Genomic Database (CGD)

Dystonia 23AD

Manifestation: Cardiovascular; Neurologic

Intervention: Cardiovascular

Rationale: As the condition can include cardiac arrhythmias, awareness may allow surveillance and early management

Refs: 21370267; 25296916; 30982612Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CACNA1B variants in ClinVar

9 Conditions Cataloged
not providedTotal: 1617
not specifiedTotal: 514
CACNA1B-related disorderTotal: 78
Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movementsTotal: 74
Dystonia 23Total: 6
See casesTotal: 3
Complex neurodevelopmental disorder with motor featuresTotal: 2
EBV-positive nodal T- and NK-cell lymphomaTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_000718.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
596
clinvar
7
clinvar
608
missense
647
clinvar
50
clinvar
2
clinvar
699
nonsense
14
clinvar
6
clinvar
1
clinvar
21
start loss
2
clinvar
2
frameshift
20
clinvar
5
clinvar
7
clinvar
1
clinvar
33
splice donor/acceptor (+/-2bp)
1
clinvar
15
clinvar
16
clinvar
3
clinvar
35
Total352667865091398

Highest pathogenic variant AF is 0.000006956416

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 24 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_000718.4RefSeqNP_000709.147MANE Select
ENST00000371372.6EnsemblENSP00000360423.147MANE Select
NM_001243812.2RefSeqNP_001230741.147Standard
ENST00000277551.6EnsemblENSP00000277551.247Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Synaptic vesicle cycle - Homo sapiens (human)
  • Retrograde endocannabinoid signaling - Homo sapiens (human)
  • GABAergic synapse - Homo sapiens (human)
  • Serotonergic synapse - Homo sapiens (human)
  • Dopaminergic synapse - Homo sapiens (human)

Biological Process

  • calcium ion transport
  • chemical synaptic transmission
  • neurotransmitter secretion
  • locomotory behavior
  • regulation of heart contraction

Molecular Function

  • amyloid-beta binding
  • voltage-gated calcium channel activity
  • calcium channel activity
  • calcium ion binding
  • protein binding

Cellular Component

  • plasma membrane
  • voltage-gated calcium channel complex
  • dendrite
  • neuronal cell body
  • presynapse

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000371372
Coding exons
47
Length
246836
Individuals with no LoFs
117913
Homozygous LoFs
0
Heterozygous LoFs
6765
Defined
124678
p
0.0275
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense4.528411.30e+30.6470.000082115050
Missense (PolyPhen)198375.010.527994039
Synonymous-0.4165465341.020.00003484663
Loss of Function7.85161010.1580.000005261179

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0240.021notable
Latino/Admixed American0.0260.021notable
Ashkenazi Jewish0.0560.045notable
East Asian0.0190.017notable
Finnish0.0270.022notable
European (Non-Finnish)0.0350.030notable
South Asian0.0440.036notable
Other0.0290.025notable

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1B gives rise to N-type calcium currents. N-type calcium channels belong to the 'high-voltage activated' (HVA) group and are specifically blocked by omega-conotoxin-GVIA (AC P01522) (AC P01522) (By similarity). They are however insensitive to dihydropyridines (DHP). Calcium channels containing alpha-1B subunit may play a role in directed migration of immature neurons. {ECO:0000250|UniProtKB:Q02294}.;
Disease
DISEASE: Dystonia 23 (DYT23) [MIM:614860]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT23 is an autosomal dominant dystonia affecting the face, neck, limbs. Some DYT23 patients manifest generalized myoclonus in addition to progressive action-induced multifocal dystonia. {ECO:0000269|PubMed:25296916}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.215

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Indispensability pred.
E
Indispensability score
0.892

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.